1. Home
  2. SUPN vs BHC Comparison

SUPN vs BHC Comparison

Compare SUPN & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$51.67

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Bausch Health Companies Inc.

BHC

Bausch Health Companies Inc.

HOLD

Current Price

$5.88

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
BHC
Founded
2005
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.5B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
SUPN
BHC
Price
$51.67
$5.88
Analyst Decision
Strong Buy
Hold
Analyst Count
5
3
Target Price
$61.60
$8.67
AVG Volume (30 Days)
754.8K
2.2M
Earning Date
02-24-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.97
Revenue
$681,539,000.00
$10,029,000,000.00
Revenue This Year
$8.18
$6.81
Revenue Next Year
$22.15
$4.11
P/E Ratio
N/A
$6.08
Revenue Growth
4.54
5.86
52 Week Low
$29.16
$4.25
52 Week High
$57.65
$8.69

Technical Indicators

Market Signals
Indicator
SUPN
BHC
Relative Strength Index (RSI) 61.38 34.44
Support Level $47.29 $5.62
Resistance Level $49.71 $5.85
Average True Range (ATR) 1.40 0.20
MACD 0.05 -0.05
Stochastic Oscillator 100.00 19.35

Price Performance

Historical Comparison
SUPN
BHC

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Share on Social Networks: